Fellowship · St. Louis, MO
Sponsored by Washington University/B-JH/SLCH Consortium
Empagliflozin in Patients with Chronic Kidney Disease.
The New England journal of medicine · 2023 · 2,075 citations · Katherine Tuttle
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes.
The New England journal of medicine · 2024 · 1,462 citations · Katherine Tuttle
Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association.
Circulation · 2023 · 1,648 citations · Katherine Tuttle
Development and Validation of the American Heart Association's PREVENT Equations.
Circulation · 2024 · 976 citations · Katherine Tuttle
A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association.
Circulation · 2023 · 1,080 citations · Katherine Tuttle
Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection.
JAMA · 2023 · 730 citations · Katherine Tuttle
Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials.
The lancet. Diabetes & endocrinology · 2025 · 273 citations · Katherine Tuttle
Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association.
Circulation · 2023 · 630 citations · Katherine Tuttle